Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Acceptability of Prophylactic Prostatectomy for People At High Genetic Risk of Developing Prostate Cancer: a Qualitative Study

NCT06470685 is registered in ClinicalTrials.gov with Royal Marsden NHS Foundation Trust as lead sponsor.

NCT NCT06470685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06470685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Acceptability of Prophylactic Prostatectomy for People At High Genetic Risk of Developing Prostate Cancer: a Qualitative Study
Lead sponsor
Royal Marsden NHS Foundation Trust
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 24, 2024
Completion date
June 24, 2025
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brca mutation, genetic predisposition to disease, prostate cancer